Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Collegium Pharmaceutical revenue
Collegium Pharmaceutical's revenue is $310.0 million.
What is Collegium Pharmaceutical's revenue?
- Collegium Pharmaceutical's revenue growth from 2016 to 2020 is 18,018.99%.
- Collegium Pharmaceutical has 266 employees, and the revenue per employee ratio is $1,165,473.
- Collegium Pharmaceutical peak revenue was $310.0M in 2020.
- Collegium Pharmaceutical annual revenue for 2019 was 296.7M, 5.81% growth from 2018.
- Collegium Pharmaceutical annual revenue for 2020 was 310.0M, 4.49% growth from 2019.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Collegium Pharmaceutical historical revenue
Collegium Pharmaceutical annual revenue
Collegium Pharmaceutical annual revenue over time
| Fiscal year / year | Collegium Pharmaceutical revenue |
|---|---|
| 2016 | $1.7M |
| 2017 | $28.5M |
| 2018 | $280.4M |
| 2019 | $296.7M |
| 2020 | $310.0M |
How accurately did Collegium Pharmaceutical's revenue projections match actual performance?
Collegium Pharmaceutical annual growth
Collegium Pharmaceutical saw the greatest revenue growth in 2017, when revenue increased by 1,564.29%.
Collegium Pharmaceutical had the lowest revenue growth in 2021, when revenue changed by -10.69%.
Collegium Pharmaceutical annual growth rate over time
| Year | Collegium Pharmaceutical growth |
|---|---|
| 2017 | 1564%↑ |
| 2018 | 885%↑ |
| 2019 | 6%↑ |
| 2020 | 4%↑ |
Collegium Pharmaceutical jobs nearby
Do you work at Collegium Pharmaceutical?
Is Collegium Pharmaceutical transparent about its revenue structure?
Collegium Pharmaceutical financial information
| CEO | Joseph J. Ciaffoni |
| Company Type | Public |
| Employees Number | 266 |
| Date Founded | 2002 |
| Headquarters | Stoughton, Massachusetts |
| Number of Locations | 1 |
| Revenue | $310.0M |
| Net Income | -$25,002,000 |
| Gross Proft | $240.5M (2020) |
| PE Ratio | 23.83 |
| Tax Rate | 0.0% |
| Market Capitalization | $637.5M |
| Total Assets | $1,174,131,000 |
| Ticker | COLL |
Collegium Pharmaceutical jobs you might like
Collegium Pharmaceutical financing
Collegium Pharmaceutical received early financing of $3.0M on 2003-10-28.
| Series | Round size | Date |
|---|---|---|
| Series A | $3M | 10/2003 |
| Series C | $5.5M | 11/2006 |
| Series D | $20M | 07/2008 |
| Debt Financing | $1M | 03/2010 |
| Series Unknown | $22.5M | 02/2012 |
| Series Unknown | $4M | 10/2013 |
| Private Equity | $50M | 03/2015 |
Collegium Pharmaceutical investors
| Investors | Security type |
|---|---|
| Boston Millennia Partners | Series A |
| Boston Millennia Partners | Series C |
| Westfield Capital Management | Series C |
| Boston Millennia Partners | Series D |
| Westfield Capital Management | Series D |
| Frazier Healthcare Partners | Series D |
| Boston Millennia Partners | Series Unknown |
| Skyline Ventures | Series Unknown |
| Frazier Healthcare Partners | Series Unknown |
| Longitude Capital | Series Unknown |
| Eventide Asset Management | Private Equity |
| EcoR1 Capital LLC | Private Equity |
| Boston Millennia Partners | Private Equity |
| Skyline Ventures | Private Equity |
| Frazier Healthcare Partners | Private Equity |
| Adage Capital Management | Private Equity |
| Aperture Venture Partners | Private Equity |
| Longitude Capital | Private Equity |
| TPG Biotech | Private Equity |
| RA Capital Management | Private Equity |
| Rock Springs Capital | Private Equity |
Collegium Pharmaceutical competitors
Collegium Pharmaceutical's top competitor, Teva Pharmaceuticals, earned an annual revenue of $16.5B.
Collegium Pharmaceutical's smallest competitor is Upm Pharmaceuticals, Inc. with revenue of $460.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| DURECT | - | $2.0M | 88 | - |
| Zogenix | - | $81.7M | 90 | - |
| Jazz Pharmaceuticals | - | $4.1B | 1,210 | - |
| Cerimon Pharmaceuticals | - | $760,000 | 4 | - |
| Teva Pharmaceuticals | - | $16.5B | 4,999 | - |
| INNOVUS PHARMACEUTICALS, INC. | - | $763.9M | 20 | - |
| Trevi Therapeutics | - | $905.2M | 20 | - |
| Avanir Pharmaceuticals | - | $115.0M | 200 | - |
| Axsome Therapeutics | - | $385.7M | 29 | - |
| UCB | - | $5.7B | 7,600 | - |
Collegium Pharmaceutical revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Collegium Pharmaceutical highest paying jobs
Zippia gives an in-depth look into the details of Collegium Pharmaceutical, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Collegium Pharmaceutical. The employee data is based on information from people who have self-reported their past or current employments at Collegium Pharmaceutical. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Collegium Pharmaceutical. The data presented on this page does not represent the view of Collegium Pharmaceutical and its employees or that of Zippia.
Collegium Pharmaceutical may also be known as or be related to COLLEGIUM PHARMACEUTICAL INC, COLLEGIUM PHARMACEUTICAL, INC, Collegium Pharmaceutical, Collegium Pharmaceutical Inc and Collegium Pharmaceutical, Inc.